roche alzheimer news - Search News

Roche, Alzheimer's

Bloomberg on MSN · 8h

Roche Discloses Patient Death in Alzheimer’s Trial

An elderly patient died in a clinical study of Roche Holding AG’s experimental treatment for Alzheimer’s disease, prompting changes to the trial design, although the company said overall results support further testing.

Early data from Roche’s Alzheimer’s therapy show it’s hitting targets

An Alzheimer’s drug from Roche cleared a protein that’s a hallmark of the disease from patients’ brains, suggesting the drug shows promise.

FierceBiotech · 3h

Roche sees rapid amyloid clearing in Alzheimer’s study, adjusts protocol after patient death

Early data suggest Roche’s antibody may safely and quickly remove amyloid plaque for patients with Alzheimer’s disease, though the mid-stage study has been tied to one death. | Early data suggest Roche’s antibody may safely and quickly remove amyloid plaque for patients with Alzheimer’s disease,

Pharmalittle: We’re reading about disappointing Lilly sales, a Roche Alzheimer’s therapy, and more

An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ ...

21hon MSN

AbbVie’s Deal for Alzheimer’s Antibody Raises Curtain for Roche News on Wednesday

The transaction, seen as a vote of confidence, has put the focus on other drug firms testing similar barrier-bridging ...

ENDPOINTS NEWS32m

Roche presents early-stage results for latest amyloid-based Alzheimer's attempt

Roche revealed early-stage data for a new Alzheimer’s program on Wednesday as it seeks to jump back into a field littered ...

8h

A Blood Test for Alzheimer’s

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

FierceBiotech8d

Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet

Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s ...

Pharmaceutical Technology2h

Roche to leverage Dyno Therapeutics tech for novel gene therapies in neuro disorders

With the formation of a new strategic partnership, Dyno Therapeutics is responsible for the development of novel AAV capsids.

Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

7d

Roche CEO Is Optimistic on Coming Alzheimer’s Trial Results

Roche Holding AG said its third-quarter sales rose thanks to eye drug Vabysmo as well as medicines for cancer, hemophilia and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results